Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $447,831 | $2,024,850 | $2,271,725 | $3,391,702 |
| Dep. & Amort. | $324,140 | $305,685 | $264,745 | $188,923 |
| Deferred Tax | $0 | -$13,853 | -$7,564 | $44,118 |
| Stock-Based Comp. | $0 | $0 | $46,641 | $83,242 |
| Change in WC | -$268,472 | -$849,232 | -$699,141 | -$190,960 |
| Other Non-Cash | $593,503 | -$273,572 | -$526,777 | -$2,093,230 |
| Operating Cash Flow | $1,097,002 | $1,150,438 | $1,357,501 | $1,423,796 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$356,554 | -$313,757 | -$448,603 | -$368,620 |
| Net Acquisitions | -$367,354 | -$356,930 | -$663,086 | -$251,365 |
| Inv. Purchases | -$6,176,067 | -$2,142,064 | -$2,203,325 | -$3,187,794 |
| Inv. Sales/Matur. | $2,151,048 | $1,173,926 | $430,284 | $1,062,650 |
| Other Inv. Act. | $9,805 | -$257,283 | $95,364 | -$37,557 |
| Investing Cash Flow | -$4,739,122 | -$1,896,108 | -$2,789,366 | -$2,782,684 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$500,764 | $683,774 | $1,488,578 | $492,320 |
| Stock Issued | $0 | $0 | $23,722 | $23,633 |
| Stock Repurch. | -$270,890 | -$29,850 | -$426,599 | -$515,953 |
| Dividends Paid | -$642,156 | -$589,867 | -$432,463 | -$261,721 |
| Other Fin. Act. | -$288,601 | -$71,864 | $179,738 | -$393,692 |
| Financing Cash Flow | -$1,702,410 | -$7,806 | $809,254 | -$163,093 |
| Forex Effect | -$6,917 | $8,793 | $26,934 | -$59,565 |
| Net Chg. in Cash | -$5,351,448 | -$382,800 | -$595,677 | -$1,581,546 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,399,941 | $7,782,741 | $8,378,418 | $9,959,963 |
| End Cash | $2,048,494 | $7,399,941 | $7,782,741 | $8,378,418 |
| Free Cash Flow | $740,447 | $836,681 | $908,898 | $1,055,177 |